Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers. - Wikidata - awgldk - TriplyDB

Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.

Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.

http://www.wikidata.org/entity/Q33796825

about

SCaMC-1 promotes cancer cell survival by desensitizing mitochondrial permeability transition via ATP/ADP-mediated matrix Ca(2+) buffering A self-sequestered calmodulin-like Ca²⁺ sensor of mitochondrial SCaMC carrier and its implication to Ca²⁺-dependent ATP-Mg/P(i) transport Multifaceted role of prohibitin in cell survival and apoptosis Proteomic identification of plasma biomarkers in uterine leiomyoma.Proteome differences between male and female fetal cells in amniotic fluid.Redox- and expression-proteomic analysis of plasma biomarkers in bladder transitional cell carcinoma.Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer Proteomics analysis of the DF-1 chicken fibroblasts infected with avian reovirus strain S1133.Retinal proteins associated with redox regulation and protein folding play central roles in response to high glucose conditions.Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy.Loss of COX5B inhibits proliferation and promotes senescence via mitochondrial dysfunction in breast cancer Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?Effect of glutathione reductase knockdown in response to UVB-induced oxidative stress in human lung adenocarcinoma Mitochondrial dynamics regulates migration and invasion of breast cancer cells.Targeting proteomics to investigate metastasis-associated mitochondrial proteins.Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.Hyaluronic acid-dependent protection against UVB-damaged human corneal cells.Hyaluronic acid-dependent protection against alkali-burned human corneal cells.High glucose-induced proteome alterations in retinal pigmented epithelium cells and its possible relevance to diabetic retinopathy.Mitochondria and cancer: past, present, and future.Proteomic analysis of prognostic plasma biomarkers in peripheral arterial occlusive disease.

P2860

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

P2860

Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.

http://www.wikidata.org/entity/Q33796825

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.

@ast

Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.

@en

type

label

Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.

@ast

Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.

@en

prefLabel

Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.

@ast

Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.

@en

P1433

Q33796825-9E06260B-7CBC-4EEF-B560-6117BEFE9804

P1476

Q33796825-143E7843-9E2A-41D1-A463-16BAE4BAF68D

P2093

Q33796825-02D65932-1164-4050-881B-8A6EB10FFEE4

Q33796825-13C64482-F2F6-4C1E-8CD6-0E7B642D708D

Q33796825-1D03A751-6DCC-4809-B401-5FCB88832866

Q33796825-253476BD-22F5-4851-88AE-FAB994DB2400

Q33796825-3C7F05B9-FA21-4E4A-9AB4-7F34E08C8BC1

Q33796825-8A852532-2F24-439F-ACAE-5E353667650D

Q33796825-AF6A6A7C-4449-4F2C-BED4-2FC97AEC82F4

Q33796825-B1EE7A26-C166-428C-BB18-EA78B16FAE60

Q33796825-B65ED1A0-E984-4FDA-8D2A-3E3366F0C988

Q33796825-BD97CC61-906A-4AB8-8753-EA151E5A9CC1

P2860

Q33796825-0DD3323A-8A6F-44F4-A993-6F6A0A357109

Q33796825-16DA15F1-5146-4295-800C-05862A0B70D0

Q33796825-1BF7627D-A763-45CC-BC8F-F2AC8A583D59

Q33796825-1ED07AE0-7FAD-410A-96A3-B17D95624CAD

Q33796825-3691FC5E-F99C-489D-97C9-25096723F70A

Q33796825-38CFDFA4-6109-4875-938A-C4DF38ED7889

Q33796825-3ED97DE6-36D0-4A45-A8E4-541C4DDA2649

Q33796825-43DBC82C-8242-48E7-A243-C04E5071E997

Q33796825-45D231E0-2DDA-4EB1-B535-C1FB12AE5886

Q33796825-4839FFDC-5430-4988-94AA-0490E11D5A65

P2888

Q33796825-95CDA47C-79F2-4BDC-A68B-6B6108433D0F

P304

Q33796825-BFCCE0E9-50F0-4040-8A3C-1EDEB9CF47D5

P31

Q33796825-184947F6-D34F-46BE-A10D-81A051AF1D9D

P356

Q33796825-0BC95480-5B51-4353-A699-E264CF37C621

P433

Q33796825-C99CD3B3-F7B0-4E88-ADD4-A87090D024E2

P478

Q33796825-788B6C03-11EA-477C-94AA-5C4C36C10C37

P577

Q33796825-9D06D15F-747D-4E78-923D-FC028665A883

P6179

Q33796825-34AFCF13-A58E-49F5-AEFF-CF2F55A51999

P698

Q33796825-3337F653-9CAA-4FC3-91E1-B62715C4060D

P356

S10142-011-0210-Y

P1433

Functional and Integrative Genomics

P1476

Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.

@en

P2093

Chiao-Yuan Fan

http://www.w3.org/2001/XMLSchema#string

Chieh-Lin Wu

http://www.w3.org/2001/XMLSchema#string

Fang-Liang Huang

http://www.w3.org/2001/XMLSchema#string

Hong-Lin Chan

http://www.w3.org/2001/XMLSchema#string

Hsien-Sheng Yin

http://www.w3.org/2001/XMLSchema#string

Hsiu-Chuan Chou

http://www.w3.org/2001/XMLSchema#string

I-Fan Tu

http://www.w3.org/2001/XMLSchema#string

Ping-Chiang Lyu

http://www.w3.org/2001/XMLSchema#string

Shun-Hong Huang

http://www.w3.org/2001/XMLSchema#string

Szu-Ting Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells

Mortalin-MPD (mevalonate pyrophosphate decarboxylase) interactions and their role in control of cellular proliferation

Mitochondrial functions and estrogen receptor-dependent nuclear translocation of pleiotropic human prohibitin 2

Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase

Mitochondrial DNA mutations in human disease

Trypsin-induced proteome alteration during cell subculture in mammalian cells

Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein

Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization

Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing

Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.

P2888

s10142-011-0210-y

P304

225-239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10142-011-0210-Y

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030568992

http://www.w3.org/2001/XMLSchema#string

P698

21246238

http://www.w3.org/2001/XMLSchema#string